雲南白藥(000538.SZ):擬成立北京大學-雲南白藥國際醫學研究中心
格隆匯1月2日丨雲南白藥(000538.SZ)公佈,近日,公司收到北京大學《關於成立北京大學-雲南白藥國際醫學研究中心的通知》。《通知》稱:經北京大學研究決定,成立北京大學-雲南白藥國際醫學研究中心,英文名稱為Peking UniversityYunnan Baiyao International Medical Research Center。該中心為校內獨立實體研究機構。
在國家科技創新驅動、健康中國戰略、以及中國製造2025等方針政策的指導下,為加強醫學學科建設的交叉發展,着眼前沿性、國際化,公司與北京大學基於合作共贏的原則,成立北京大學-雲南白藥國際醫學研究中心,通過充分發揮北京大學的人才吸引優勢和雲南白藥的市場化優勢,在醫藥衞生健康領域開展項目合作。
此次合作旨在通過資源互補、強強聯合,相互支持、互惠共贏,進一步鞏固和擴大雙方在各自領域中的優勢,實現最佳的經濟效益和社會效益,符合公司長期戰略發展方向,將在未來較長時期內對公司業務發展和經營業績提升產生積極影響。此次合作不會影響公司業務的獨立性,公司主營業務不會因此而對合作方形成依賴。此次合作對公司2020年度的經營業績不構成重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.